Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page. This change represents a version bump rather than a substantive modification to the content or layout.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a new revision label, updating from v3.5.2 to v3.5.3. This indicates a minor editorial or system-level update rather than a change to the study information.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study details or page content.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; this is a metadata change and does not alter the study details.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.4.2 was added and the v3.4.1 notice was removed. This appears to be a site maintenance update that does not affect the clinical trial details on the page.SummaryDifference0.5%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.